AIDA BRAX: Open Payments
NPI 1215587340 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Viatris Specialty LLC | 2 | $52 |
| Novo Nordisk Inc | 2 | $41 |
| ABBVIE INC. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Pulmonx Corporation | 1 | $23 |
| Philips North America LLC | 1 | $22 |
| VIVUS LLC | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: YUPELRI, TEZSPIRE, NUCALA, Wegovy, AVYCAZ, TRELEGY ELLIPTA, DUPIXENT, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
